What is a “breakthrough” case? It’s when a vaccinated person gets infected. Experts say COVID-19 vaccines still help reduce the severity of any illness in such cases.
What is a COVID-19 vaccine “breakthrough” case? It’s when a fully vaccinated person gets infected with the coronavirus.
In studies, the two-dose COVID-19 vaccines by Pfizer and Moderna were around 95% effective at preventing illness, while the one-shot Johnson & Johnson shot was 72% effective, thoughare difficult. So while the vaccines are very good at protecting us from the virus, it’s still possible to get infected with mild or no symptoms, or even to get very sick.
If you do end up getting sick despite vaccination, experts say the shots help reduce the severity of the illness — the main reason to get vaccinated. But the understanding of how vaccinated people who are infected might spread the virus to others is changing.Previously, health officials believed vaccinated people who get breakthrough infections were unlikely to spread the virus. But with the more contagious delta variant that is now dominant, the U.S. Centers for Disease Control and Prevention said new data shows people who get infected could carry enough virus in their noses and throats to spread it to others.
Still, health experts say the vaccines provide strong protection against serious illness. In the U.S., people who weren’t vaccinated make up nearly all hospitalizations and deaths from COVID-19.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Covid-19: Health Trusts cancel surgeries as Covid admissions riseThe chief medical officer says the health service is operating under 'huge pressures'.
Consulte Mais informação »
Experts turn to antibody treatment following swarm of breakthrough COVID-19 infectionsReports of uncommon breakthrough cases among fully vaccinated Americans, coupled with the delta variant tearing through the country, threaten to undermine the fiercely fought wins against the pandemic. For the fully vaccinated who do test positive, if you are at high risk for severe infection, health experts are now turning to Food and Drug Administration authorized, virus-fighting monoclonal antibodies in some cases. 'Receiving antibody treatments in a timely manner could be the difference of ending up in the hospital or getting over COVID (quickly),' Dr. Shmuel Shoham, infectious disease physician at Johns Hopkins University School of Medicine, told ABC News.
Consulte Mais informação »
Pfizer Raises Full-Year Outlook on Covid-19 Vaccine SalesThe pharmaceutical company’s Covid-19 vaccine co-developed with BioNTech contributed $7.8 billion to Pfizer’s total sales of $18.98 billion in the latest quarter.
Consulte Mais informação »
LA County COVID-19 hospitalizations nearly double in 2 weeksLos Angeles County is seeing an uptick in COVID-19-related hospitalizations, with the number of patients nearly doubling over the last two weeks, health officials said.
Consulte Mais informação »
Pfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variantA third dose of the Pfizer/BioNTech Covid-19 vaccine can 'strongly' boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday.
Consulte Mais informação »